Day: Biotech
Needs Review
Sprind funding for two Munich biotech startups
Insempra and Global Sustainable Transformation GST have been selected as participants in the Sprind Challenge "Circular Biomanufacturing." This means that the two Munich-based startups will…
Deals
Epiqmax acquired by Moleqlar
In the third quarter of this year, the biotech startup Epiqmax filed for insolvency with the local court. Now, the Berlin-based company Moleqlar has…
Needs Review
BioM honors four Munich startups with M4 Award
With the M4 Award, BioM and the Bavarian State Ministry for Economic Affairs, Regional Development and Energy recognize innovative research projects in the field of biomedicine…
ecosystem
Capsitec receives 2.5 million euros in Sprind funding
The Munich-based startup Capsitec has been selected by the Federal Agency for Disruptive Innovations for the third and final phase of the Sprind Challenge “Broad-Spectrum Antivirals”…
Inside Stories
Protegg: Transforming waste into raw materials
Every day, 12,000 tons of waste are generated in egg production. The Munich-based startup Protegg is taking on the challenge of converting these waste materials into…
Deals
AATec Medical launches with 2.7 million euros in seed financing
The biotech startup AATec Medical is working on a novel anti-inflammatory drug for the treatment of respiratory diseases. In its seed financing round, the company secured…
Deals
Spin-off from TUM: Invitris secures quarter of a million euros
With the financial support of the Incate consortium, the startup Invitris aims to expand its production of antimicrobial proteins to combat antibiotic resistance…
Needs Review
Thermosome starts Phase I clinical trial
The Munich-based startup Thermosome specializes in the targeted treatment of tumors. The company has now announced its first…
Deals
Smartbax closes seed round with 1.2 million euros
Smartbax is developing antibiotics against multi-resistant bacteria. The Munich-based biotech company has closed its seed round with €1.2 million.
Deals
Amsilk expands Series C to €54 million
It's actually been a while since Amsilk was able to attract investors for its Series C: At the beginning of 2021, the biotech startup secured...
Deals
Series A: 13 million euros for Mbiomics
The Munich-based biotech company Mbiomics, which develops microbiome-based therapeutics, has secured a Series A round of €13 million. In addition to Bayern Kapital,…
Needs Review
How Munich biotech startups are fighting cancer
Munich is one of Germany's leading biotech hubs. Research is conducted here on a wide variety of medications and therapies, including cancer. We…
